Detection of visual and frontoparietal network perfusion deficits in Parkinson's disease dementia
Özet
Mild cognitive impairment of Parkinson's disease (PD) may be an early manifestation that may progressively worsen to dementia. Cognitive decline has been associated with changes in the brain perfusion pattern. This study aimed to evaluate cerebral blood flow (CBF) deficits specific to different stages of cognitive decline. Seventeen patients with cognitively normal PD (PD-CN), 18 patients with PD with mild cognitive impairment (PD-MCI), and 16 patients with PD with dementia (PDD) were included in this study. The participants were scanned using a 3 T Philips MRI scanner. Arterial spin labelling magnetic resonance (ASL-MR) images were acquired, followed by calculation of the CBF maps, and registration onto the MNI152 brain atlas. A whole-brain voxel-based CBF comparison was performed among the patient groups using age as a covariate. The mean age of patients with PDD was significantly higher than that of patients with PD-MCI (P = 0.015) and PD-CN (P = 0.001). The CBF values of the three groups were significantly different in the left cuneus of the visual network (VN), left inferior frontal gyrus of the frontoparietal network (FPN), and left dorsomedial nucleus of the thalamus. PDD had lower perfusion values than PD-MCI group in the same regions detected in the main group analysis. Additionally, comparison of PDD with PD-CN and non-demented groups revealed that the perfusion reduction extended into the bilateral cuneus of the VN, bilateral thalami, and left inferior frontal gyrus of the FPN. PDD could be separated from PD-MCI and PD-CN stages with CBF deficits in non-dopaminergically mediated posterior and dopaminergically mediated frontal networks. © 2021
Kaynak
European Journal of RadiologyCilt
144Koleksiyonlar
İlgili Öğeler
Başlık, yazar, küratör ve konuya göre gösterilen ilgili öğeler.
-
Evaluation of upper extremity performance in patients with Parkinson's disease: Comparison of Nine Hole Peg Test values with Unified Parkinson's Disease Rating Scale [Parkinson hastalarinda üst ekstremite performansinin de?erlendirilmesi: Dokuz Delikli Peg Testi ile Birleş tirilmiş Parkinson Hastali?i De?erlendirme Ölçe?i'nin karşilaştirilmasi]
Öguz S.; Tekeo?lu A.; Mutluay F.; Işsever H.; Kiziltan G.; Özekmekçi S.; Gürses H.N. (2009)Purpose: To compare the "Nine Hole Peg Test" (NHPT) with "Unified Parkinson's Disease Rating Scale" (UPDRS) in the evaluation of upper extremity performance. Materials and methods: Eighty seven patients with Parkinson's ... -
Evaluation of upper extremity performance in patients with Parkinson's disease: Comparison of Nine Hole Peg Test values with Unified Parkinson's Disease Rating Scale [Parkinson hastalarinda üst ekstremite performansinin değerlendirilmesi: Dokuz Delikli Peg Testi ile Birleş tirilmiş Parkinson Hastaliği Değerlendirme Ölçeği'nin karşilaştirilmasi]
Purpose: To compare the "Nine Hole Peg Test" (NHPT) with "Unified Parkinson's Disease Rating Scale" (UPDRS) in the evaluation of upper extremity performance. Materials and methods: Eighty seven patients with Parkinson's ... -
Lacosamide exhibits neuroprotective effects in a rat model of Parkinson's disease
Bilal B.; Kirazlar M.; Erdogan M.A.; Yigitturk G.; Erbas O. (Elsevier B.V., 2023)Background: Parkinson's disease (PD) is a chronic and progressive neurodegenerative disorder that primarily affects the motor system. Although there are several treatments available to alleviate PD symptoms, there is ...